Drug
TD 1473 For Sad
TD 1473 For Sad: highest development phase Phase 1, developed by Theravance Biopharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Theravance Biopharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| TD-1473 for SAD NCT02657122 | Phase 1 | Healthy |
Latest
No recent events.
Follow TD 1473 For Sad on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.